Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1995722

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1995722

US AI in Rehabilitation Robotics Market - Strategic Insights and Forecasts (2026-2031)

PUBLISHED:
PAGES: 86 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2850
PDF & Excel (Multi User License - Up to 5 Users)
USD 3450
PDF & Excel (Enterprise License)
USD 5850

Add to Cart

The US AI in Rehabilitation Robotics Market will expand from USD 2,114.5 million in 2026 to USD 5,518.9 million in 2031, reflecting a 21.2% CAGR.

The US AI in rehabilitation robotics market is emerging as a transformative segment within digital healthcare and medical robotics. Rehabilitation robotics combines advanced robotics with artificial intelligence technologies to assist patients recovering from neurological disorders, musculoskeletal injuries, and mobility impairments. AI-powered rehabilitation systems enable adaptive therapy, real-time patient monitoring, and data-driven treatment planning. These technologies help healthcare providers deliver more precise and personalized rehabilitation programs while improving patient outcomes.

The growing burden of chronic neurological conditions, including stroke and spinal cord injuries, is a key structural factor supporting market expansion. Healthcare providers are increasingly adopting AI-enabled robotic systems to manage rising patient volumes while maintaining high-quality rehabilitation services. These systems allow therapists to monitor patient progress using sensor data and machine learning algorithms that adjust therapy intensity and motion parameters in real time. The integration of intelligent robotics into rehabilitation centers and hospitals is transforming conventional therapy practices into automated and data-driven clinical workflows.

The United States remains a leading market for rehabilitation robotics due to its advanced healthcare infrastructure, strong medical research ecosystem, and favorable reimbursement policies. Insurance coverage for robotic-assisted rehabilitation therapies is gradually improving, which reduces financial barriers for healthcare institutions investing in these technologies. As healthcare systems increasingly emphasize precision medicine and outcome-based care models, AI-driven rehabilitation robotics platforms are becoming an important tool for improving long-term recovery outcomes.

Market Drivers

One of the primary drivers of the US AI in rehabilitation robotics market is the increasing prevalence of neurological and mobility disorders. Stroke, spinal cord injuries, Parkinson's disease, and orthopedic conditions create a significant demand for long-term physical rehabilitation services. AI-powered robotic systems enable repetitive and precise therapeutic exercises, which are essential for neuroplasticity and motor function recovery. These systems provide consistent therapy sessions while reducing the physical workload on rehabilitation specialists.

Another important growth driver is the shortage of trained rehabilitation therapists. As patient populations requiring physical therapy continue to expand, healthcare systems face increasing pressure to deliver efficient and scalable rehabilitation services. AI-enabled robotics help address this challenge by automating certain therapy tasks and enabling therapists to supervise multiple patients simultaneously.

The growing adoption of data-driven healthcare technologies also supports market growth. AI algorithms analyze patient movement patterns, muscle activity, and recovery progress to personalize treatment protocols. This capability allows rehabilitation programs to adapt dynamically based on patient response, improving treatment effectiveness and reducing recovery time.

Market Restraints

Despite strong growth potential, the US AI in rehabilitation robotics market faces several challenges. One of the main barriers is the high initial capital cost associated with robotic rehabilitation systems. Advanced robotic platforms incorporate sophisticated sensors, actuators, and AI software, which increases procurement costs for hospitals and rehabilitation clinics. Smaller healthcare facilities may find it difficult to justify such investments without clear reimbursement structures.

Another restraint is the complexity of integrating robotic systems into existing clinical workflows. Healthcare providers must train medical staff, update clinical protocols, and ensure interoperability with electronic health record systems. These integration challenges may slow adoption among institutions with limited technical expertise.

Technology and Segment Insights

The market can be segmented by robot type, application, and end-user settings. From a technology perspective, machine learning and computer vision play key roles in enabling intelligent rehabilitation robots. These systems analyze real-time sensor data to assess patient movement, identify deviations, and adjust therapy parameters accordingly.

Robot types commonly deployed in rehabilitation include exoskeleton robots, assistive robots, and prosthetic rehabilitation systems. Exoskeleton robots are widely used for gait training and mobility rehabilitation in patients recovering from spinal cord injuries or stroke. Assistive robots help patients perform repetitive limb exercises and strength training activities.

Application areas include neurological rehabilitation, orthopedic therapy, and post-surgical recovery programs. Neurological rehabilitation represents a major segment due to the growing incidence of stroke and other neurological disorders requiring long-term physical therapy.

End users include hospitals, rehabilitation centers, research institutions, and home healthcare settings. Hospitals and specialized rehabilitation clinics represent the largest adoption segment due to their access to advanced medical infrastructure and specialized therapy programs.

Competitive and Strategic Outlook

The competitive landscape of the US AI in rehabilitation robotics market includes medical robotics manufacturers, healthcare technology companies, and research-driven startups. Companies are investing heavily in AI algorithms that enable adaptive therapy and improve robotic movement precision.

Strategic partnerships between robotics manufacturers, rehabilitation hospitals, and research institutions are accelerating innovation in the market. These collaborations help develop clinically validated robotic systems capable of supporting complex rehabilitation programs. Companies are also focusing on expanding their product portfolios with modular robotic platforms that can be customized for different therapeutic applications.

Key Takeaways

The US AI in rehabilitation robotics market is evolving rapidly as artificial intelligence and robotics technologies reshape rehabilitation medicine. AI-enabled robotic systems provide personalized therapy, improve treatment consistency, and support more efficient rehabilitation workflows. While high implementation costs and integration challenges remain, increasing demand for advanced rehabilitation solutions and continuous technological innovation are expected to drive sustained market growth.

Key Benefits of this Report

  • Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What businesses use our reports for

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2025 and forecast data from 2026 to 2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments
Product Code: KSI061618163

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. US AI IN REHABILITATION ROBOTICS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Exoskeleton Robots
  • 5.3. Prosthetics Robots
  • 5.4. Assistive Robots
  • 5.5. Therapeutic Robots

6. US AI IN REHABILITATION ROBOTICS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Stroke Rehabilitation
  • 6.3. Spinal Cord Injury Rehabilitation
  • 6.4. Orthopedic Rehabilitation
  • 6.5. Neurological Rehabilitation
  • 6.6. Others

7. US AI IN REHABILITATION ROBOTICS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals And Clinics
  • 7.3. Rehabilitation Centers
  • 7.4. Research Institutes and Academic Centers
  • 7.5. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Ekso Bionics Holdings, Inc.
  • 9.2. Lifeward Ltd.
  • 9.3. Bionik Laboratories Corp.
  • 9.4. Hocoma Ag (Dih Technologies)
  • 9.5. Myomo, Inc.
  • 9.6. Parker Hannifin Corporation
  • 9.7. Tyromotion Gmbh
  • 9.8. Focal Meditech Bv

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key Benefits for the Stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!